Identification of a novel NAMPT inhibitor by CRISPR/Cas9 chemogenomic profiling in mammalian cells
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Identification of a novel NAMPT inhibitor by CRISPR/Cas9 chemogenomic profiling in mammalian cells
Authors
Keywords
-
Journal
Scientific Reports
Volume 7, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-02-16
DOI
10.1038/srep42728
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Myc-Driven Glycolysis Is a Therapeutic Target in Glioblastoma
- (2016) K. Tateishi et al. CLINICAL CANCER RESEARCH
- Parallel shRNA and CRISPR-Cas9 screens enable antiviral drug target identification
- (2016) Richard M Deans et al. Nature Chemical Biology
- High-Resolution CRISPR Screens Reveal Fitness Genes and Genotype-Specific Cancer Liabilities
- (2015) Traver Hart et al. CELL
- Natural products as probes in pharmaceutical research
- (2015) Esther K. Schmitt et al. JOURNAL OF INDUSTRIAL MICROBIOLOGY & BIOTECHNOLOGY
- MYC and metabolism on the path to cancer
- (2015) Annie L. Hsieh et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Structural Basis for Resistance to Diverse Classes of NAMPT Inhibitors
- (2014) Weiru Wang et al. PLoS One
- Mapping the Cellular Response to Small Molecules Using Chemogenomic Fitness Signatures
- (2014) A. Y. Lee et al. SCIENCE
- Next-Generation NAMPT Inhibitors Identified by Sequential High-Throughput Phenotypic Chemical and Functional Genomic Screens
- (2013) Christina J. Matheny et al. CHEMISTRY & BIOLOGY
- High-resolution chemical dissection of a model eukaryote reveals targets, pathways and gene functions
- (2013) Dominic Hoepfner et al. MICROBIOLOGICAL RESEARCH
- Genetic Screens in Human Cells Using the CRISPR-Cas9 System
- (2013) Tim Wang et al. SCIENCE
- The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
- (2012) Jordi Barretina et al. NATURE
- The c-MYC oncoprotein, the NAMPT enzyme, the SIRT1-inhibitor DBC1, and the SIRT1 deacetylase form a positive feedback loop
- (2011) A. Menssen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- How I treat paroxysmal nocturnal hemoglobinuria
- (2009) R. A. Brodsky BLOOD
- The NAD biosynthesis inhibitor APO866 has potent antitumor activity against hematologic malignancies
- (2009) A. Nahimana et al. BLOOD
- Structure and reaction mechanism of human nicotinamide phosphoribosyltransferase
- (2009) Ryo Takahashi et al. JOURNAL OF BIOCHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started